Simple doctor alert could prevent deadly pregnancy complication

NCT ID NCT07614893

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether notifying obstetric clinicians when a pregnant patient is at high risk for preeclampsia increases the use of low-dose aspirin, which can help prevent the condition. Researchers will compare clinics that receive these alerts to those that continue usual care. The goal is to improve prevention of a leading cause of pregnancy-related illness and death.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
clinician notification (behavioral intervention)
What this could lead to
If successful, this could increase the use of low-dose aspirin to prevent preeclampsia in high-risk pregnancies, reducing maternal illness and death.
What could go wrong
This is an implementation trial, not testing a new drug. It may not change doctor behavior significantly, and aspirin use still depends on individual clinical judgment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASPIRIN PROPHYLAXIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mass General Brigham

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.